Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy: A case report

RATIONALE: Anti-PD-1 antibody is the standard therapy for treatment-resistant gastric cancer, but only a limited number of patients respond. Additionally, cases of hyper-progressive disease (HPD) in which tumor growth accelerates after anti-PD-1 antibody administration have been reported; however, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Kyoko, Tsuchihashi, Kenji, Tsuji, Kunihiro, Kito, Yosuke, Tanoue, Kenro, Ohmura, Hirofumi, Ito, Mamoru, Isobe, Taichi, Ariyama, Hiroshi, Kusaba, Hitoshi, Akashi, Koichi, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133284/
https://www.ncbi.nlm.nih.gov/pubmed/34106609
http://dx.doi.org/10.1097/MD.0000000000025773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133284/
https://www.ncbi.nlm.nih.gov/pubmed/34106609
http://dx.doi.org/10.1097/MD.0000000000025773

Ejemplares similares